Drugs / FLU D-PAN H1N1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01008813 | Oct 2009 → Feb 2010 | HIV infectious disease | French National Agency for Research on AIDS and Viral Hepatitis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLU D-PAN H1N1 | “of FLU D-PAN H1N1 \[A/California/7/2009 (H1N1)v\] (3,8 microgram) adjuvanted with AS 03A” NCT01008813 ↗ |
| Modality | Vaccine | “adjuvanted A(H1N1)v influenza vaccine” NCT01008813 ↗ |
| Route | Intramuscular | “Two intramuscular injections at day 0 and day 21” NCT01008813 ↗ |